The Lancet

CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma?

bSbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA ...